Up next
Share article
The post has been shared by 0 people.
Mail 0
LinkedIn 0
Twitter 0

Podcast 23: Injectable Drugs: CDMOs/CMOs and Suppliers Expand

In this podcast we feature a roundup of up expansions by CDMOs/CMOs and other suppliers in injectable drug development and manufacturing.

Key topics: (see Chapter Markers)

  • Injectable drugs and recent drug approvals
  • Manufacturing expansions and technology advances
  • A roundup of CDMO/CMO expansions thus far in 2020
  • Vetter
  • Catalent
  • Grand River Aseptic Manufacturing
  • CordenPharma
  • Alcami
  • Thermo Fisher Scientific
  • Recipharm
  • Samsung Biologics
  • PCI Pharma Services
  • WuXi Biologics
  • Bushu Pharmaceuticals
  • Evonik
  • LSNE Contract Manufacturing
  • Berkshire Sterile Manufacturing
  • Integrity Bio
  • Argonaut Manufacturing Services
  • Suppliers of packaging materials and components for injectable drugs expand
  • Corning
  • Stevanato Group
  • Schott
  • West Pharmaceutical Services

Sponsor: Vetter Pharma International GmbH

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Podcast 44: What’s Trending: Parenteral Drug Development & Manufacturing

What are some key trends and issues arising in parenteral drug development and manufacturing? From more complex molecules and modalities and sterile drug-product capacity market shifts, DCAT Value Chain Insights…

Podcast 43: CDMOs/CMOs: The Movers and Shakers of 2023

As 2023 comes to a close, what were the largest mergers and acquisitions and expansions made by CDMOs/CMOs in 2023? DCAT Value Chain Insights looks at which companies topped the…

Podcast 42: CDMO/CMO Mid-Year Review: Tracking the Key Moves Thus Far in 2023 

As we near the mid-year mark, what have been the key moves—mergers and acquisitions, expansions, and new CDMOs entering the market—thus far in 2023? DCAT Value Chain Insights takes an…

Podcast 41: API Alert: EU Proposes New Requirements To Secure Pharma Supply Chains 

The European Commission has issued its long-awaited proposal to reform pharmaceutical legislation in the EU, the first major overhaul in 20 years, which includes new requirements to address drug shortages…